151. Fibrinolytic agents inhibit platelet adhesion onto collagen type I-coated surfaces at high blood flow conditions
- Author
-
Alevriadou Br, Dionne A. Graham, Nelson Ld, and Huang Tc
- Subjects
Platelet Aggregation ,Plasmin ,Platelet Membrane Glycoproteins ,Platelet membrane glycoprotein ,chemistry.chemical_compound ,Platelet Adhesiveness ,Fibrinolytic Agents ,Von Willebrand factor ,Platelet adhesiveness ,von Willebrand Factor ,Image Processing, Computer-Assisted ,medicine ,Humans ,Streptokinase ,Platelet ,Ristocetin ,Microscopy, Video ,biology ,Chemistry ,Fibrinogen ,Hematology ,General Medicine ,Urokinase-Type Plasminogen Activator ,Adenosine Diphosphate ,Perfusion ,Biochemistry ,Depression, Chemical ,Hemorheology ,biology.protein ,Biophysics ,Platelet aggregation inhibitor ,Collagen ,Platelet Aggregation Inhibitors ,Fibrinolytic agent ,medicine.drug - Abstract
The effect of fibrinolytic agents on platelet adhesion onto insolubilized collagen type I was evaluated. Normal human whole blood samples were incubated with agents and perfused over collagen-coated surfaces in a parallel-plate flow chamber. Platelet adhesion and aggregation were analyzed by video microscopy and image processing. When blood was perfused at 1500/s, both streptokinase and urokinase, each at 500 U/ml, caused a significantly less normalized platelet deposition, compared with controls. At 480/s, platelet deposition was not different between controls and test samples. Inhibition of platelet deposition at high flow rates was partly due to inhibition of platelet adhesion. Both ristocetin- and ADP-induced platelet aggregation were inhibited in test samples. The agents caused proteolytic degradation of plasma fibrinogen, but no degradation of platelet glycoproteins Ib and IIb-IIIa (GPIb and GPIIb-IIIa) and of plasma von Willebrand factor in test samples prior to perfusion. Post-perfusion von Willebrand factor degradation was not found. Plasmin may cause functional changes to plasma proteins and/or platelet receptors, altering their adhesive properties under flow. At high shear, fibrinogen degradation products may interfere with GPIIb-IIIa binding to insolubilized von Willebrand factor, leading to decreased platelet adhesion. Inhibition of platelet adhesion by thrombolytic agents could help maintain vessel patency after recanalization in stenosed arteries. Publishers.
- Published
- 1998
- Full Text
- View/download PDF